Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
17.90
-0.33 (-1.81%)
At close: Feb 3, 2026, 4:00 PM EST
17.96
+0.06 (0.34%)
Pre-market: Feb 4, 2026, 7:08 AM EST
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $1.76 billion as of February 4, 2026. Its market cap has increased by 236.07% in one year.
Market Cap
1.76B
Enterprise Value
1.60B
1-Year Change
236.07%
Ranking
Category
Stock Price
$17.90
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $1.76B, an increase of 196.17%. That is a compound annual growth rate of 20.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.76B | 33.68% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 1.87B |
| Syndax Pharmaceuticals | 1.86B |
| MannKind | 1.84B |
| Zai Lab | 1.83B |
| Pharvaris | 1.79B |
| Corvus Pharmaceuticals | 1.76B |
| Nurix Therapeutics | 1.76B |
| Stoke Therapeutics | 1.76B |